Diffuse & Symbiotic partner to introduce collateral abstraction in decentralized finance
Diffuse, a zkServerless protocol, has announced a strategic collaboration with Symbiotic ecosystem to implement Collateral ...
World’s First Potential Target Therapy for Diffuse Gastric Cancer Granted Fast Track Designation by the U.S. FDA
Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Targeted Oncology2d
FDA Gives Dordaviprone Priority Review in H3K27M-Mutant Diffuse Glioma
The FDA has granted a priority review to dordaviprone for treating patients with recurrent H3K27M-mutant diffuse glioma, a ...
Medscape26d
Reflections on Early Challenges and Experiences in Treating DLBCL
Matthew S. McKinney, MD, reflects on his first experience of treating a patient with diffuse large B-cell lymphoma (DLBCL) as a new attending at Duke University. The patient, a woman with multiple ...
Medscape26d
Addressing Disparities in DLBCL Treatment and Outcomes
Suchitra Sundaram, MD, emphasizes the significant disparities in the treatment and outcomes of patients with diffuse large B-cell lymphoma (DLBCL), which arise from a complex interaction of ...
Business Wire16d
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously ...
About diffuse large B-cell lymphoma Lymphoma is cancer beginning in the lymphatic system – the network of organs, vessels and tissues that protects the body from infection. There are many ...
Impacts3d
Diffuse and Symbiotic Partner to Introduce Collateral Abstraction in Decentralized Finance, Unlocking New DeFi Potential
Diffuse, a cutting-edge zkServerless protocol, has announced a groundbreaking strategic collaboration with the Symbiotic ...